#mnibdwebinar — Public Fediverse posts

3/#MondayNightIBD #GITwitter #MedTwitter
#Crohns #PerianalFistula #CPF
@BonumCe

👇Answer Pre-Polls before watching 👇

---
RT @MondayNightIBD
1/#PreConvo #IBDPoll #Crohns #PerianalFistula
#MNIBDWebinar #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-CME

🟢Where are you in your career?
https://twitter.com/MondayNightIBD/status/1623338318015639552

3/#MondayNightIBD #GITwitter #MedTwitter
#Crohns #PerianalFistula #CPF
@BonumCe

👇Answer Pre-Polls before watching 👇

---
RT @MondayNightIBD
1/#PreConvo #IBDPoll #Crohns #PerianalFistula
#MNIBDWebinar #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-CME

🟢Where are you in your career?
https://twitter.com/MondayNightIBD/status/1623338318015639552

#GITwitter #MondayNightIBD
⏰tick tick boom⏰
Just 15 min away - #Crohns #PerianalFistula #MNIBDWebinar ⏰

Our experts @AmyLightnerMD #DrMarlaDubinsky @DCharabaty

📌Initial & MDT mgmt
📌Mgmt following med failure
📌Focus on stem cell tx
📌#PatientExperience w Brandon Pomish

#GITwitter #MondayNightIBD
⏰tick tick boom⏰
Just 15 min away - #Crohns #PerianalFistula #MNIBDWebinar ⏰

Our experts @AmyLightnerMD #DrMarlaDubinsky @DCharabaty

📌Initial & MDT mgmt
📌Mgmt following med failure
📌Focus on stem cell tx
📌#PatientExperience w Brandon Pomish

5/#PreConvo #IBDPoll 4⃣
#MNIBDWebinar #Crohns #PerianalFistula #CPF

🟢According to the 2022 proposed new Expert Consensus @LancetGastroHep http://bit.ly/3l6UgIb refractory #Crohn #PerianalFistula #PF despite ostomy requiring proctectomy is considered which class?

5/#PreConvo #IBDPoll 4⃣
#MNIBDWebinar #Crohns #PerianalFistula #CPF

🟢According to the 2022 proposed new Expert Consensus @LancetGastroHep http://bit.ly/3l6UgIb refractory #Crohn #PerianalFistula #PF despite ostomy requiring proctectomy is considered which class?

4/#PreConvo #IBDPoll 3⃣
#MNIBDWebinar #Crohns #PerianalFistula #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-Pre2

🟢42yo F w refractory #CPF #Fistula asks about possibility of receiving Mesenchymal #StemCell MSC therapy on a clinical trial. What do you tell them about the process? MSCs are:

4/#PreConvo #IBDPoll 3⃣
#MNIBDWebinar #Crohns #PerianalFistula #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-Pre2

🟢42yo F w refractory #CPF #Fistula asks about possibility of receiving Mesenchymal #StemCell MSC therapy on a clinical trial. What do you tell them about the process? MSCs are:

2/#PreConvo #IBDPoll 1️⃣
#MNIBDWebinar #Crohns #PerianalFistula #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-Pre2

🟢The addition of which of the following to an anti-TNF agent is associated with a higher rate of #Crohns #PerianalFistula CPF healing vs the anti-TNF agent alone?

2/#PreConvo #IBDPoll 1️⃣
#MNIBDWebinar #Crohns #PerianalFistula #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-Pre2

🟢The addition of which of the following to an anti-TNF agent is associated with a higher rate of #Crohns #PerianalFistula CPF healing vs the anti-TNF agent alone?

1/#PreConvo #IBDPoll #Crohns #PerianalFistula
#MNIBDWebinar #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-CME

🟢Where are you in your career?

1/#PreConvo #IBDPoll #Crohns #PerianalFistula
#MNIBDWebinar #CPF

🆓#CME🔗http://bit.ly/CPF-MNIBD-CME

🟢Where are you in your career?

📣#GITwitter
Join⚕️@DCharabaty @AmyLightnerMD #DrMarlaDubinsky+ Brandon Pomish 4 #Crohns #PerianalFistula

🗓️#CPF #MNIBDWebinar Sat 2/11
🎯MultiD Mgmt
🎯Stem Cell Therapy
🎯#PatientExperience

🆓#CME👉http://bit.ly/CPF-MNIBD-CME
🗳️#IBDPolls👇
🔸Supported by an edu grant @TakedaPharma

📣#GITwitter
Join⚕️@DCharabaty @AmyLightnerMD #DrMarlaDubinsky+ Brandon Pomish 4 #Crohns #PerianalFistula

🗓️#CPF #MNIBDWebinar Sat 2/11
🎯MultiD Mgmt
🎯Stem Cell Therapy
🎯#PatientExperience

🆓#CME👉http://bit.ly/CPF-MNIBD-CME
🗳️#IBDPolls👇
🔸Supported by an edu grant @TakedaPharma

#MNIBDWebinar #GITwitter #PedsGI

📌Want to get straight to the point of #ShortBowelSyndrome ?

⏩Sections

1:45 SBS definition
3:43 Complications of SBS
5:00 Goals of Care
6:20 Nutrition & Fluid Mgmt
9:51 Medical Mgmt
14:17 Teduglutide
17:50 Real World Experience

#MNIBDWebinar #GITwitter #PedsGI

📌Want to get straight to the point of #ShortBowelSyndrome ?

⏩Sections

1:45 SBS definition
3:43 Complications of SBS
5:00 Goals of Care
6:20 Nutrition & Fluid Mgmt
9:51 Medical Mgmt
14:17 Teduglutide
17:50 Real World Experience

12/#ICYMI #MondayNightIBD
💡 Focus: #MNIBDWebinar #pediatric patients w/ #ShortBowelSyndrome

---
RT @MondayNightIBD
⌛️#GITwitter #PedsGI - the wait is over!
🎆 Join @valcohranmd & @DCharabaty
📽️#MNIBDWebinar🎞#ShortBowelSyndrome Consult w the Expert

#CME👉 🔗http://bit.ly/sbs-consult-1-cmeinfo
👇#PostConvo #IBDPolls

Supported by an educational grant from @TakedaPharma https://twitter.com/i/broadcasts/1PlKQpRZXDDxE
https://twitter.com/MondayNightIBD/status/1569446068492062720

12/#ICYMI #MondayNightIBD
💡 Focus: #MNIBDWebinar #pediatric patients w/ #ShortBowelSyndrome

---
RT @MondayNightIBD
⌛️#GITwitter #PedsGI - the wait is over!
🎆 Join @valcohranmd & @DCharabaty
📽️#MNIBDWebinar🎞#ShortBowelSyndrome Consult w the Expert

#CME👉 🔗http://bit.ly/sbs-consult-1-cmeinfo
👇#PostConvo #IBDPolls

Supported by an educational grant from @TakedaPharma https://twitter.com/i/broadcasts/1PlKQpRZXDDxE
https://twitter.com/MondayNightIBD/status/1569446068492062720

8/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

🔴 #PostConvo #IBDPoll 4⃣
🏅 #CME ➡️ http://bit.ly/SBS-Consult2

🔴Which of the following is considered to be a potentially disease-modifying treatment for pts w/ #ShortBowelSyndrome?

8/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

🔴 #PostConvo #IBDPoll 4⃣
🏅 #CME ➡️ http://bit.ly/SBS-Consult2

🔴Which of the following is considered to be a potentially disease-modifying treatment for pts w/ #ShortBowelSyndrome?

5/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

🔴#PostConvo #IBDPoll 1️⃣
🏅 #CME ➡️ http://bit.ly/SBS-Consult2

🔴The GLP-2 analog teduglutide was shown in clinical studies to be associated w/ which of the following outcomes?

5/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

🔴#PostConvo #IBDPoll 1️⃣
🏅 #CME ➡️ http://bit.ly/SBS-Consult2

🔴The GLP-2 analog teduglutide was shown in clinical studies to be associated w/ which of the following outcomes?

3/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

🟠Full CME ℹ️ 🔗http://bit.ly/3wLGPzF
🟠Make sure you answer the pre-polls! 👉 http://bit.ly/3JOd7BU

🔴 Where are you in your career?

3/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

🟠Full CME ℹ️ 🔗http://bit.ly/3wLGPzF
🟠Make sure you answer the pre-polls! 👉 http://bit.ly/3JOd7BU

🔴 Where are you in your career?

2/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

Earn 🆓 #CME 🎫
ℹ️ 🔗 http://bit.ly/3wLGPzF

📸 Faculty disclosures & important CME info 👇

2/#MondayNightIBD #GITwitter #PedsGI #MedEd #MedTwitter #MNIBDWebinar #BonumCE

Earn 🆓 #CME 🎫
ℹ️ 🔗 http://bit.ly/3wLGPzF

📸 Faculty disclosures & important CME info 👇

📣#GITwitter #PedsGI

⚕️Join experts @valcohranmd @Subramanian1MD ⚕️& @DCharabaty addressing the long & the short of:

🎯Optimizing care of #ShortBowelSyndrome

🏆🆓 #CME 🔗http://bit.ly/3wLGPzF
Supported by an edu grant @TakedaPharma
---
RT @MondayNightIBD
🩺Short Bowel Syndrome Medical Mgmt #MNIBDWebinar 🩺🔸 CME 🔗http://bit.ly/3wLGPzF 🔸 Supported by an edu grant from @TakedaPharma https://twitter.com/i/broadcasts/1OwGWwrNVLQGQ
https://twitter.com/MondayNightIBD/status/1622716313415344129

🩺Short Bowel Syndrome Medical Mgmt #MNIBDWebinar 🩺🔸 CME 🔗http://bit.ly/3wLGPzF 🔸 Supported by an edu grant from @TakedaPharma https://twitter.com/i/broadcasts/1OwGWwrNVLQGQ

📣#GITwitter #PedsGI

⚕️Join experts @valcohranmd @Subramanian1MD ⚕️& @DCharabaty addressing the long & the short of:

🎯Optimizing care of #ShortBowelSyndrome

🏆🆓 #CME 🔗http://bit.ly/3wLGPzF
Supported by an edu grant @TakedaPharma
---
RT @MondayNightIBD
🩺Short Bowel Syndrome Medical Mgmt #MNIBDWebinar 🩺🔸 CME 🔗http://bit.ly/3wLGPzF 🔸 Supported by an edu grant from @TakedaPharma https://twitter.com/i/broadcasts/1OwGWwrNVLQGQ
https://twitter.com/MondayNightIBD/status/1622716313415344129

🩺Short Bowel Syndrome Medical Mgmt #MNIBDWebinar 🩺🔸 CME 🔗http://bit.ly/3wLGPzF 🔸 Supported by an edu grant from @TakedaPharma https://twitter.com/i/broadcasts/1OwGWwrNVLQGQ

@TemaraHajjat Dr Dubinsky is one of our favs too!! Be sure to join us for our #MNIBDWebinar on Tuesday! #MondayNightIBD